Morphocell Technologies
PrivateLast Round
Series A
Dec 1, 2025
Total Funding Raised
$91.68M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Morphocell Technologies is a biotechnology company developing stem cell–derived tissue and organ replacement therapies with an initial focus on liver disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Morphocell Technologies Comparables
Compare Morphocell Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Satellite Bio | 88% | |
| LyGenesis | 88% | |
| HepaTx Corporation | 85% |
Morphocell Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2025 | ||||
| Grant | Jun 19, 2025 | ||||
| Series A | Feb 1, 2024 | ||||
| Seed | Jul 7, 2021 | ||||
| Grant | Mar 2, 2020 |
Key People
Founding team and executive leadership
Morphocell Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gensen Capital | Series A |
| Stem Cell Network | Seed, Grant, Pre Seed |
| Investissement Québec | Series A |
| Investissement Québec | Series A |
| Consortium Québécois sur la découverte du médicament | Grant, Seed |
| CDP Venture Capital SGR | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Open roles increased to 9, 4.5x the trailing average.
- Dec 1, 2025
$10M round completed.
Morphocell Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Morphocell Technologies's valuation, stock price, and market status.
Is Morphocell Technologies a public or private company?
Morphocell Technologies is a private company.
What is the current stock price of Morphocell Technologies?
Morphocell Technologies is a private company, so its shares have no public market price. Caplight tracks Morphocell Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Morphocell Technologies worth (valuation)?
Valuation information for Morphocell Technologies is not publicly available.
Can I buy Morphocell Technologies stock?
Morphocell Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Morphocell Technologies's last funding round?
Morphocell Technologies's most recent funding round was Series A on December 1, 2025.
Who are the main investors in Morphocell Technologies?
Key investors in Morphocell Technologies include Gensen Capital, Stem Cell Network, Investissement Québec, Investissement Québec, Consortium Québécois sur la découverte du médicament.
Will Morphocell Technologies IPO soon?
No public IPO plans have been announced for Morphocell Technologies.
How can I track Morphocell Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Morphocell Technologies's shares on secondary markets.